Literature DB >> 6112528

Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson's syndrome.

M T Jones, B Gillham, U Beckford, A Dornhorst, R R Abraham, M Seed, V Wynn.   

Abstract

Six patients with Nelson's syndrome were given sodium valproate with or without diazepam for 3 or 5 weeks. Initial high plasma adrenocorticotropic hormone (ACTH) concentrations were greatly reduced by treatment and returned to high levels when treatment was stopped. Diazepam did not add significantly to the effects of sodium valproate alone. Three patients reported a decrease in the severity and frequency of headaches while on sodium valproate. In five patients abnormal skin pigmentation was reduced. Sodium valproate is a gamma-aminobutyric acid (GABA) transaminase inhibitor and it is suggested that the drug raises GABA levels in the hypothalamus and that this is responsible for the reduction in ACTH secretion. The data are consistent with the hypothesis that Nelson's syndrome is a neuroendocrine disease caused by a deficiency in the hypothalamic GABA-ergic system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112528     DOI: 10.1016/s0140-6736(81)92349-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

Review 1.  Treating Cushing's disease.

Authors:  W J Jeffcoate
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-23

2.  Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.

Authors:  B Ambrosi; D Bochicchio; E Riva; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

3.  Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.

Authors:  R Pivonello; A Faggiano; F Di Salle; M Filippella; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

4.  The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.

Authors:  M Reincke; B Allolio; D Kaulen; C Jaursch-Hancke; W Winkelmann
Journal:  Klin Wochenschr       Date:  1988-08-01

5.  Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.

Authors:  P Loli; M E Berselli; F Frascatani; F Muratori; M Tagliaferri
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

6.  Evaluation of surgically treated Nelson's syndrome.

Authors:  D K Lüdecke; H J Breustedt; J Brämswig; J Köbberling; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

7.  Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.

Authors:  Dongyun Zhang; Robert Damoiseaux; Lilit Babayan; Everett Kanediel Rivera-Meza; Yingying Yang; Marvin Bergsneider; Marilene B Wang; William H Yong; Kathleen Kelly; Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.